Melkert
appointed Associate Administrator of UNDP
UNITED
NATIONS, Jan 18: Ad Melkert of the Netherlands has
been appointed Associate Administrator of the
United Nations Development Progamme, the world
body has announced.
Melkert, who will
begin work on March 1 next, has represented the
Dutch constituency as an Executive Director of
the World Bank.
Previously,
Melkert was active in the international and
European youth movements and worked for Novib, a
Dutch non-governmental organization (NGO) focused
on development issues.
He served as
Minister of Social Affairs and Employment, and in
Parliament was a member of the Standing
Committees for Foreign Affairs and Development
Cooperation.
As Associate
Administrator, Melkert will oversee the UNDP's
programme operations, as well as take on other
responsibilities in the organization.
UNDP focuses on
helping developing countries build capacity in
the areas of democratic governance, conflict
prevention and recovery, poverty reduction,
energy and environment, and HIV/AIDS. (PTI)
Shanghai
to bar heavily polluting vehicles from downtown
BEIJING,
Jan 18: Shanghai, China's largest city, has
barred heavily polluting motor vehicles from
entering downtown area during peak hours.
The Shanghai
traffic authority has announced that it will
issue certificates to owners of vehicles which
meet the Euro I emission standard from January 20
to February 14.
Beginning on
February 15, buses, cars and lorries without the
special certificate will be forbidden to enter
the city's inner ring elevated roads from 0700
hrs to 2000 hrs.
Any driver in the
restricted area who fails to show a vehicle
emission certificate will be fined 200 yuan (25
U.S. Dollars).
Environmental
experts expect the latest move will affect about
350,000 motor vehicles, around one-third of
Shanghai's approximate 950,000 cars, buses and
trucks.
From October one,
all motor vehicles that emit pollutants exceeding
the Euro I standard will be prohibited access to
all the inner-ring roads between 0700 hrs and
2000 hrs, 'China Daily' reported.
Vehicles coming
from other towns, which will stay in Shanghai for
more than a week, are also required to apply for
the certificate at one of the 16 road-toll
service agents.
Shanghai will
adopt the stricter Euro III standard on vehicle
emission in the city next year and probably
adhere to the Euro IV standard in 2009,
vice-director of Shanghai Environmental
Protection Bureau, Sun Jian said.
Air pollution
caused by vehicle exhausts has become an
increasing problem in Shanghai as car sales have
grown steeply in recent years.
It is estimated
that at least 6,000 vehicles are sold in the
eastern metropolis every month. (PTI)
Desmopressin
improves nighttime urination in men
NEW
YORK, Jan 18: Desmopressin safely relieves
frequent nighttime urination or ''nocturia'' in
elderly men who've tried other medications to
control their problem, which is related to
obstruction by the prostate gland, researchers in
Taiwan report.
''We need to
recognize this drug's safety and correct
application,'' Dr Chih-Shou Chen from Chang Gung
Memorial Hospital, Chia-Yi, told Reuters.
Chen and
colleagues investigated the response of nighttime
voiding to desmopressin and other drugs called
alpha-blockers in 28 men with nocturia due to
prostate gland obstruction.
Twenty-four men
experienced improvements in nocturia while taking
desmopressin, the authors report. The average
number of voids at night declined from 6.1 to
3.5. Desmopressin seemed to be more effective in
men with more severe nocturia.
Improvements in
nocturia did not appear related to the dose of
desmopressin used, the researchers note, as
similar effects were seen with doses of 0.1
milligram and with higher doses. Treatment with
desmopressin was also well tolerated, according
to the report in BJU International.
Desmopressin is
effective ''in patients with nocturia and
decreased nocturnal functional bladder capacity
but who do not have nocturnal polyuria,'' a
condition in which large urine voids occur, the
authors conclude.
''Vasopressin may
result in water retention in certain cases,
especially for those patients who receive
long-term treatment,'' Chen added. ''Therefore,
desmopressin at bedtime combined with certain
diuretics in the morning may be helpful for them.
Our study of this approach will be completed in
the near future.'' (AGENCIES)
Chronic
illness common among veterans
NEW
YORK, Jan 18: Chronic illness characterised by a
complex of multiple symptoms is more common in
deployed Gulf War I (1991) veterans than in
nondeployed veterans, according to a report in
the American Journal of Epidemiology.
''Veterans with
multiple complaints may have chronic multisymptom
illness,'' Dr Melvin S Blanchard from St Louis
Veterans Affairs Medical Center, St Louis, told
Reuters Health. ''It is important to seek
co-morbid conditions such as depression, anxiety,
metabolic syndrome, and treat them.''
Dr Blanchard and
colleagues investigated the prevalence of chronic
multisymptom illness and related factors in 2189
veterans who participated in the examination
phase of the National Health Survey of Gulf War
Era Veterans and Their Families 10 years after
the 1991 Gulf War.
The researchers
defined chronic multisymptom illness as the
presence, for 6 months or longer, of one or more
symptoms from at least two of the following
clusters: general fatigue, mood and cognitive
abnormalities, and musculoskeletal pain.
Nearly 29 per cent
of deployed veterans and 16 per cent of
nondeployed veterans experienced chronic
multisymptom illness, the investigators report.
Seven per cent of deployed veterans and 1.6 per
cent of nondeployed veterans had severe symptoms.
Among deployed
veterans, higher levels of combat exposure were
associated with chronic multisymptom illness, the
results indicate.
Both groups of
veterans with chronic multisymptom illness had
significantly more clinic visits, and more
prescription medication use than did veterans
without chronic multisymptom illness, the
researchers note.
Chronic
multisymptom illness was significantly associated
with fibromyalgia syndrome, chronic fatigue
syndrome, joint pain, dyspepsia, and metabolic
syndrome, the report indicates.
After adjustment
for other risk factors, prewar anxiety disorders
and depression were strongly associated with
chronic multisymptom illness, regardless of
deployment status.
Stress management
programmes and improvements in lifestyle, such as
increased exercise and diet education, may help
minimize symptoms, Blanchard added. Also,
identifying and treating co-existing psychiatric
illnesses ''is extremely important.'' (AGENCIES)
Poor
diabetes control may be better for some
NEW
YORK, Jan 18: People with diabetes are always
exhorted to keep their blood sugar levels under
control, but in some cases the advice might not
be appropriate.
Contrary to what
has been shown in otherwise healthy diabetics,
elevated hemoglobin A1c levels -- an indicator of
poor glucose control -- are associated with
improved survival among diabetics with advanced
heart failure, new research shows.
''The presumption
was that better glycemic control would be
associated with better outcomes'' senior author
Dr Gregg C Fonarow, from the University of
California at Los Angeles, told Reuters.
''Yet, in previous
studies, a number of factors normally tied to
adverse outcomes, such as high cholesterol
levels, have been linked to improved outcomes in
patients with heart failure.'' So, it was unclear
what to expect with elevated hemoglobin A1c
levels, he added.
In the study,
reported in the American Heart Journal, the
outcomes of 49 diabetics with A1c levels no
greater than 7 were compared with those of 74
patients with higher levels. All of the patients
had advanced heart failure.
''The American
Diabetes Association recommends a target
hemoglobin A1c of 7.0 or lower, which is why we
used this'' cutoff, Fonarow explained.
The researchers
found that poor glucose control was associated
with an all-cause mortality of 20 per cent during
2 years of follow-up, significantly lower than
the 35 per cent rate seen in patients with
recommended levels of blood sugar control.
''This study alone
should not change the diabetes management of
patients with heart failure, but hopefully it
will spur further research in this patient
population,'' Fonarow said. (AGENCIES)
|